MedTrace Logo

Methocarbamol in Treatment of Muscle Cramps in Cirrhotic Patients

NCT02642874 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-07-24

No results posted yet for this study

Summary

Muscle cramps markedly affect the quality of life in cirrhotic patients with no highly effective drug. Methocarbamol is a central muscle relaxant used to treat skeletal muscle spasms. The mechanism of action of methocarbamol is currently unknown, but may involve the inhibition of carbonic anhydrase. Methocarbamol has a high therapeutic index, i.e. a wide range of safe and effective dosages.

Conditions

Interventions

DRUG

Methocarbamol

Methocarbamol twice daily

DRUG

Calcium Carbonate

Calcium carbonate twice daily

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Sherief M. Abd-Elsalam, Consultant · liver diseases dept.- Tanta university hospital

  • Walaa A. Elkhalawany, Consultant · liver diseases dept.- Tanta university hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02642874 on ClinicalTrials.gov